# Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

> **NCT04863703** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hannover Medical School** · enrollment: 11 (estimated)

## Conditions studied

- Hepatitis D
- Hepatitis B
- Portal Hypertension
- Liver Cirrhosis

## Interventions

- **DRUG:** Bulevirtide

## Key facts

- **NCT ID:** NCT04863703
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-07
- **Primary completion:** 2024-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863703, "Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04863703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*